JP2010509281A5 - - Google Patents

Download PDF

Info

Publication number
JP2010509281A5
JP2010509281A5 JP2009535724A JP2009535724A JP2010509281A5 JP 2010509281 A5 JP2010509281 A5 JP 2010509281A5 JP 2009535724 A JP2009535724 A JP 2009535724A JP 2009535724 A JP2009535724 A JP 2009535724A JP 2010509281 A5 JP2010509281 A5 JP 2010509281A5
Authority
JP
Japan
Prior art keywords
phenyl
triazol
propyl
compound
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009535724A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010509281A (ja
Filing date
Publication date
Priority claimed from EP06380289A external-priority patent/EP1921071A1/en
Application filed filed Critical
Publication of JP2010509281A publication Critical patent/JP2010509281A/ja
Publication of JP2010509281A5 publication Critical patent/JP2010509281A5/ja
Pending legal-status Critical Current

Links

JP2009535724A 2006-11-10 2007-11-07 シグマ受容体阻害剤としての1,2,3−トリアゾール誘導体 Pending JP2010509281A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06380289A EP1921071A1 (en) 2006-11-10 2006-11-10 1,2,3- triazole derivatives as sigma receptor inhibitors
PCT/EP2007/062010 WO2008055933A1 (en) 2006-11-10 2007-11-07 1,2,3-triazole derivatives as sigma receptor inhibitors

Publications (2)

Publication Number Publication Date
JP2010509281A JP2010509281A (ja) 2010-03-25
JP2010509281A5 true JP2010509281A5 (https=) 2010-12-24

Family

ID=37963991

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009535724A Pending JP2010509281A (ja) 2006-11-10 2007-11-07 シグマ受容体阻害剤としての1,2,3−トリアゾール誘導体

Country Status (12)

Country Link
US (1) US8193223B2 (https=)
EP (2) EP1921071A1 (https=)
JP (1) JP2010509281A (https=)
KR (1) KR20090087032A (https=)
CN (1) CN101589029A (https=)
AU (1) AU2007316606A1 (https=)
BR (1) BRPI0718586A2 (https=)
CA (1) CA2668996A1 (https=)
ES (1) ES2413559T3 (https=)
MX (1) MX2009004745A (https=)
RU (1) RU2009122198A (https=)
WO (1) WO2008055933A1 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2116539A1 (en) 2008-04-25 2009-11-11 Laboratorios Del. Dr. Esteve, S.A. 1-aryl-3-aminoalkoxy-pyrazoles as sigma ligands enhancing analgesic effects of opioids and attenuating the dependency thereof
EP2353591A1 (en) 2010-02-04 2011-08-10 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof
EP2388005A1 (en) 2010-05-21 2011-11-23 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy
EP2395003A1 (en) 2010-05-27 2011-12-14 Laboratorios Del. Dr. Esteve, S.A. Pyrazole compounds as sigma receptor inhibitors
EP2415471A1 (en) 2010-08-03 2012-02-08 Laboratorios Del. Dr. Esteve, S.A. Use of sigma ligands in opioid-induced hyperalgesia
EP2524694A1 (en) 2011-05-19 2012-11-21 Laboratorios Del. Dr. Esteve, S.A. Use of sigma ligands in diabetes type-2 associated pain
EP2548878A1 (en) * 2011-07-21 2013-01-23 Laboratorios Del. Dr. Esteve, S.A. Pyrazolo[3,4-d]pyrimidine compounds, their preparation and use as sigma ligands
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2752411A1 (en) * 2013-01-07 2014-07-09 Laboratorios Del Dr. Esteve, S.A. 1,2,3-triazole-4-amine derivatives for the treatment of sigma receptor related diseases and disorders
EP2792679A1 (en) * 2013-04-19 2014-10-22 Laboratorios Del. Dr. Esteve, S.A. Tricyclic triazolic compounds
TN2015000474A1 (en) 2013-04-23 2017-04-06 Esteve Labor Dr PYRAZINO[1,2-a]INDOLE COMPOUNDS, THEIR PREPARATION AND USE IN MEDICAMENTS
MX2015014905A (es) 2013-04-23 2016-03-07 Esteve Labor Dr Compuestos de pirazino - [1,2-a] indol, su preparacion y su uso en medicamentos.
EP2832720A1 (en) 2013-07-30 2015-02-04 Laboratorios Del. Dr. Esteve, S.A. 1,2-disubstituted cyclobutyl compounds
TN2016000228A1 (en) 2013-12-17 2017-10-06 Esteve Labor Dr SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS (SNRIs) AND SIGMA RECEPTOR LIGANDS COMBINATIONS.
MA41177A (fr) * 2014-12-15 2017-10-24 Esteve Labor Dr Utilisation de ligands des récepteurs sigma dans l'arthrose
ES2905878T3 (es) * 2015-01-30 2022-04-12 Neurocrine Biosciences Inc Triazoles sustituidos y métodos relacionados con los mismos
CN106866555B (zh) * 2017-02-08 2019-04-30 东南大学 1-二苯甲基-4-甲基哌嗪类化合物其制备方法和应用
WO2020123847A1 (en) * 2018-12-12 2020-06-18 Rutgers, The State University Of New Jersey Organic compounds
CN116178286B (zh) * 2021-11-26 2024-12-03 华东师范大学 一种n2烷基取代的三氮唑衍生物及其合成方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2071897A1 (en) 1989-12-28 1991-06-29 Richard A. Glennon Sigma receptor ligands and the use thereof
WO2002036119A1 (en) * 2000-11-02 2002-05-10 K And K Biosciences, Inc. Δ2,-1,2,3-triazoline anticonvulsants and their active metabolite analogues, the aminoalkylpyridines, are excitatory amino acid antagonists and antiischemic agents, useful in the treatment of cerebral ischemia resulting from stroke
WO2007056210A2 (en) * 2005-11-04 2007-05-18 Merck & Co., Inc. Diphenylmethane derivatives as inhibitors of leukotriene biosynthesis

Similar Documents

Publication Publication Date Title
JP2010509281A5 (https=)
JP2010509280A5 (https=)
RU2009122198A (ru) Производные 1,2,3-триазола в качестве ингибиторов сигма-рецепторов
RU2009122197A (ru) Производные 1,2,4-триазолы в качестве ингибиторов сигма-рецептора
DK145644B (da) Analogifremgangsmaade til fremstilling af imidazolforbindelser
HU220088B (hu) Tetrahidro-piridin- (vagy -4-hidroxi-piperidin)-alkil-azol-származékok és alkalmazásuk
JP5391269B2 (ja) ピペラジン化合物、それを含む医薬組成物
HUE034430T2 (en) Process for the preparation of triazole compounds
EP3452467A1 (de) Verfahren zur herstellung von 5-hydroxyalkyl-substituierten 1-phenyl-1,2,4-triazolderivativen
JP2016540793A5 (https=)
JP3782455B2 (ja) アポリポタンパク質−b合成阻害剤としての新規なトリアゾロン
CN1169798C (zh) 新型三氮唑醇类抗真菌化合物及其制备方法
US8772299B2 (en) Phenyl piperazine compounds, pharmaceutical composition including the same and use thereof
PT841327E (pt) Agente anti-fungico de triazole
DE60013515T2 (de) 4-Arylpiperidinderivate zur Behandlung von Pruritus
CA2249529A1 (en) New triazoles as therapeutic agents for fungal infections
US4785117A (en) 5,5-disubstituted-3-phenyl-3-phenyl-3-[(1H-imidazol-1-ylmethyl) or (1H-1,2,4-triazol-1-ylmethyl)]-2-methylisoxazolidine derivatives (IR 3012)
US4835283A (en) 3,5-diphenyl-3-[(1H-imidazol-1-ylmethyl) or (1H-1,2,4-triazol-1-ylmethyl)]-2
US4749793A (en) 5-substituted-3-phenyl-3-[1H-imidazol-1-ylmethyl) or (1H-1,2,4-triazol-1-ylmethyl]-2-benzylisoxazolidines (ir 3011)
US4767868A (en) 3-Phenyl-3-(1H-imidazol-1-ylmethyl)-2-methyl-5-[(phenylamino)methyl]isoxazolidines
US4831154A (en) 5-alkyl(or alkenyl)-3-phenyl-3-(1H-imidazol-1-ylmethyl)-2-methylisoxazolidines
US4767867A (en) 5-(alkoxyalkyl)-3-phenyl-3-(1H-imidazol-1-ylmethyl)-2-methylisoxazolidines
JP2005272450A5 (https=)
US4777264A (en) 5-carbonyl derivatives of 3-phenyl-3-(1H-imadazol-1-ylmethyl)-2-methylisoxazolidines and related compounds thereof